Resistant enterococci: A prospective study of prevalence, incidence, and factors associated with colonization in a University Hospital

Infection Control and Hospital Epidemiology

Volumn 17, Issue 1, 1996, Pages 36-41

  Weinstein, Jeffrey W ^a   Roe, Matthew ^a   Towns, Michael ^a   Sanders, Linda ^a   Thorpe, Jackie J ^a   Corey, G Ralph ^a   Sexton, Daniel J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; VANCOMYCIN;

ANALYSIS OF VARIANCE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; CROSS INFECTION; DRUG EFFECT; ENTEROCOCCUS; HUMAN; INCIDENCE; MICROBIOLOGY; PENICILLIN RESISTANCE; PREVALENCE; PROSPECTIVE STUDY; RISK; RISK FACTOR; STATISTICAL MODEL; UNITED STATES;

AMPICILLIN RESISTANCE; ANALYSIS OF VARIANCE; ANTI-BACTERIAL AGENTS; CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; ENTEROCOCCUS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INCIDENCE; LOGISTIC MODELS; NORTH CAROLINA; ODDS RATIO; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; VANCOMYCIN;

EID: 0029686469     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.2307/30142363     Document Type: Article

References (23)

1. Murray BE. The life and times of the enterococcus. Clin Microbiol Rev 1990;3:46-65.
2. Calderwood SA, Wennersten C, Moellering RC, Kunz LJ, Krogstad DJ. Resistance to six aminoglycosidic aminocyclitol antibiotics among enterococci; prevalence, evolution, and relationship to synergism with penicillin. Antimicrob Agents Chemother 1977;12:401-405.
3. Murray BE, Mederski-Samaroj B. Transferable β-lactamase: a new mechanism for in vitro penicillin resistance in Streptococcus faecalis. J Clin Invest 1988;72:1168-1171.
4. Uttley AHC, George RC, Naidoo J, et al. High level vancomycin resistant enterococci causing hospital infections. Epidemiol Infect 1989;103:173-181.
5. Centers for Disease Control and Prevention. Nosocomial enterococci resistant to vancomycin - United States, 1989-1993. MMWR 1993;42:597-599.
6. Oster SE, Chirurgi VA, Goldberg AA, Aiken S, McCabe RE. Ampicillin-resistant enterococcal species in an acute care hospital. Antimicrob Agents Chemother 1990;34:1821-1823.
7. Coudron PE, Mayhall CG, Facklam RR, et al. Streptococcus faecium outbreak in a neonatal intensive care. J Clin Microbiol 1984;20:1044-1048.
8. Axelrod P, Talbot GH. Risk factors for acquisition of gentamicin-resistant enterococci: a multivariate analysis. Arch Intern Med 1989;149:1397-1401.
9. Patterson JE, Zervos MJ. High-level gentamicin resistance in Enterococcus: microbiology, genetic basis, and epidemiology. Rev Infect Dis 1990;12:644-652.
10. Huycke MM, Spiegel CA, Gilmore MS. Bacteremia caused by hemolytic, high-level gentamicin-resistant Enterococcus faecalis. Antimicrob Agents Chemother 1991;35:1626-1634.
11. Karanfil LV, Murphy M, Josephson A, et al. A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit. Infect Control Hosp Epidemiol 1992;13:195-200.
12. Boyce JM, Opal SM, Potter-Bynoe G, et al. Emergence and nosocomial transmission of ampicillin-resistant enterococci. Antimicrob Agents Chemother 1992;36:1032-1039.
13. Rubin LG, Tucci V, Cercenado E, Eliopoulos G, Isenberg HD. Vancomycin-resistant Enterococcus faecium in hospitalized children. Infect Control Hosp Epidemiol 1992;13:700-705.
14. Boyle JF, Soumakis SA, Rendo A, et al. Epidemiologie analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci. J Clin Microbiol 1993; 31:1280-1285.
15. Handwerger S, Raucher B, Altarac D, et al. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. Clin Infect Dis 1993;16:750-755.
16. Sexton DJ, Harrell LJ, Thorpe JJ, Hunt DL, Reller LB. A case-control study of nosocomial ampicillin-resistant enterococcal infection and colonization at a university hospital. Infect Control Hosp Epidemiol 1993;14:629-635.
17. Zervos MJ, Kauffman CA, Therasse PM, Bergman AG, Mikesell TS, Schaberg DR. Nosocomial infection by gentamicin-resistant Streptococcus faecal is. Ann Intern Med 1987;106: 687-691.
18. Rhinehart E, Smith NE, Wennersten C, et al. Rapid dissemination of β-lactamase producing, aminoglycoside-resistant Enterococcus faecalis among patients and staff on an infant-toddler surgical ward. N Engl J Med 1990;323:1814-1818.
19. Facklam RR, Washington JJ. Streptococcus and related catalase-negative gram-positive cocci. In: Balows A, Hausler WJ Jr, Jerrmann KL, Isenberg HD, Shadomy NJ, eds. Manual of Clinical Microbiology. 5th ed. Washington, DC: American Society for Microbiology; 1991:238-257.
20. National Committee for Clinical Laboratory Standards. Approved Standard, M2-A5: Performance Standards for Antimicrobial Disk Susceptibility Tests. 5th ed. Villanova, PA: NCCLS; 1993.
21. National Committee for Clinical Laboratory Standards. Approved Standard. M7-A3: Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. 3rd ed. Villanova, PA: NCCLS; 1993.
22. Harrell FE, Lee KL, Califf RM, Pryor DB, Rosati RA. Regression modeling strategies for improved prognostic prediction. Stat Med 1984;3:143-152.
23. Harrell FE. The legists procedure. In: SUGI Supplemental Library Users Guide. Cary, NC: SAS Institute Inc; 1986;5: 269-293.